<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03280121</url>
  </required_header>
  <id_info>
    <org_study_id>D031517</org_study_id>
    <nct_id>NCT03280121</nct_id>
  </id_info>
  <brief_title>Hernia Reduction Prior to Scheduled TIF Completion</brief_title>
  <acronym>HEURISTIC</acronym>
  <official_title>Hernia Reduction Prior to Scheduled TIF Completion- The HEURISTIC Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EndoGastric Solutions</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EndoGastric Solutions</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hernia Reduction Prior to Scheduled TIF Completion using EsophyX ZR transoral device
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of the relative merits, safety and effectiveness of the EsophyX ZR transoral
      device in performing the standardized TIF 2.0 procedure preceded by laparoscopic Hiatal
      Hernia repair in PPI-prescribed patients with persistent &quot;troublesome symptoms&quot; per the
      Montreal consensus definition
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective, investigator initiated, multicenter, non-randomized single arm, open label.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pH study</measure>
    <time_frame>48 hour monitoring period</time_frame>
    <description>Normalization in esophageal acid exposure is defined by ≤ 5.3% of total time pH &lt; 4 in</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>reduction of troublesome symptoms</measure>
    <time_frame>1 week</time_frame>
    <description>Per Montreal Consensus definition, troublesome symptoms are mild symptoms occurring two (2) or more days per week, or moderate/severe symptoms occurring more than 1 day per week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PPI consumption reduction</measure>
    <time_frame>1 week</time_frame>
    <description>from daily use to occasional use or none at all.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Fundoplication</condition>
  <arm_group>
    <arm_group_label>TIF using EsophyX ZR transoral device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transoral incisionless fundoplication which is a minimally invasive treatment for gastroesophageal reflux disease (GERD) using EsophyX ZR transoral device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EsophyX ZR transoral device</intervention_name>
    <description>TIF</description>
    <arm_group_label>TIF using EsophyX ZR transoral device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18-65 years

          2. Dependent upon daily PPIs for &gt; 6 months. Daily use is defined as a double dose, or
             full dose or half dose taken daily for more than 80% of the total number of days
             during the proceeding evaluation period

          3. Troublesome symptoms, specifically heartburn or regurgitation, while on optimized dose
             of PPI's Troublesome heartburn or regurgitation symptoms are those which occur a
             minimum of 2 days a week and are mild to severe in severity

          4. Abnormal ambulatory (Bravo) pH study after off PPI therapy for 7 days, i.e. &gt; 5.3% of
             the time with pH &lt; 4 in a 48-hour monitoring period

          5. Normal or near normal esophageal motility (by Upper GI/ esophagram or manometry as
             required)

          6. Pre-enrollment Hiatal Hernia (axial height and transverse dimension) from &gt; 2 cm up to
             4 cm inclusive.

          7. Patient willing to cooperate with post-operative dietary recommendations and
             assessment tests at the requisite follow-up visits

          8. Signed informed consent Exclusion Criteria

        1. BMI &gt; 35 2. Hiatal hernia ≤ 2 and &gt; 4 cm 3. Esophagitis Los Angeles grade C or D 4.
        Esophageal ulcer 5. Esophageal stricture 6. Long-segment Barretts esophagus (Prague: C &gt; 1,
        M &gt; 3) 7. Esophageal motility disorder 8. Pregnancy or plans for pregnancy in the next 12
        months (in females) 9. Immunosuppression 10. ASA &gt; 2 11. Portal hypertension and/or varices
        12. History of previous resective gastric or esophageal surgery, cervical spine fusion,
        Zenker's diverticulum, esophageal epiphrenic diverticulum, achalasia, scleroderma or
        dermatomyositis, eosinophilic esophagitis, or cirrhosis 13. Active gastro-duodenal ulcer
        disease 14. Gastric outlet obstruction or stenosis 15. Severe gastroparesis or delayed
        gastric emptying confirmed by solid-phase gastric emptying study if patient complains of
        postprandial satiety during assessment 16. Coagulation disorders 17. Atypical symptoms
        including gas bloat and dysphagia. 18. Any other presenting condition that in the opinion
        of the investigator would not make participation in this study in the patient's best
        interest.

        Post Enrollment Exclusion -

        1. Inability to repair Hiatal hernia with at least 2cm of intra-abdominal esophagus length.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Cynthia C Harris, B.S.</last_name>
    <phone>7753922970</phone>
    <email>cindy@clinregconsult.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Daniel, BS,MS,MBA</last_name>
    <phone>4154070223</phone>
    <email>MADANIEL@clinregconsult.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California, Irvine Medical Center</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brian R Smith, MD</last_name>
      <email>Brian.Smith11@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Carlos Chavez, MD</last_name>
      <phone>7144565396</phone>
      <email>chavezc@ucu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Kenneth J Chang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Global Medical Center</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yasser H Salem, MD,FACS</last_name>
      <phone>714-545-5200</phone>
      <email>ysalem@theveinsurgeon.com</email>
    </contact>
    <contact_backup>
      <last_name>Lupe Sesma</last_name>
      <phone>7145455200</phone>
      <email>lupe.drsalem@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Los Robles Hospital</name>
      <address>
        <city>Thousand Oaks</city>
        <state>California</state>
        <zip>91360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gilbert Simoni, MD</last_name>
      <phone>805-497-2727</phone>
      <email>gsimoni@agimedical.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Elkhart General Hospital</name>
      <address>
        <city>Elkhart</city>
        <state>Indiana</state>
        <zip>46514</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mamoon Raza, MD</last_name>
      <phone>574-296-3200</phone>
      <email>mamoonraza@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Kate Stanley</last_name>
      <email>kstanley@elkhartclinic.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Aspirus Iron River Hospital</name>
      <address>
        <city>Iron River</city>
        <state>Michigan</state>
        <zip>49935</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Medhat Fanous, MD</last_name>
      <phone>906-265-9001</phone>
      <email>medhat.fanous@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>jeff kaliebe, MT</last_name>
      <phone>7158472273</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Northern Nevada Medical Center</name>
      <address>
        <city>Sparks</city>
        <state>Nevada</state>
        <zip>89434</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael J Murray, MD</last_name>
      <phone>775-356-4888</phone>
      <email>mmur62@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Linda McKnight</last_name>
      <phone>7754282633</phone>
      <email>linda.mcknight@uhsinc.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Easton Hospital</name>
      <address>
        <city>Easton</city>
        <state>Pennsylvania</state>
        <zip>18042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vinay Singhal, MD</last_name>
      <phone>610-253-6201</phone>
      <email>vinay.singhal@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Kriston Bradley</last_name>
      <phone>6102594305</phone>
      <email>Kriston.Brady@steward.org</email>
    </contact_backup>
    <investigator>
      <last_name>Amit Sohagia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Las Palmas Medical Center</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jorge Acosta, MD</last_name>
      <phone>915-591-7700</phone>
      <email>jorgeacostamd@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The University of Texas -Memorial Herman</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77059</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2017</study_first_submitted>
  <study_first_submitted_qc>September 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 12, 2017</study_first_posted>
  <last_update_submitted>September 9, 2017</last_update_submitted>
  <last_update_submitted_qc>September 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>transoral incisionless</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

